ADBIC
ZBH icon

A.D. Beadell Investment Counsel’s Zimmer Biomet ZBH Stock Holding History

A.D. Beadell Investment Counsel’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,625
Closed -$478K – 85
2024
Q1 		$478K Hold
3,625
– – 0.42% 56
2023
Q4 		$441K Hold
3,625
– – 0.42% 55
2023
Q3 		$406K Hold
3,625
– – 0.42% 53
2023
Q2 		$527K Sell
3,625
-2,000
-36% -$272K 0.51% 51
2023
Q1 		$726K Hold
5,625
– – 0.66% 48
2022
Q4 		$717K Sell
5,625
-250
-4% -$29K 0.62% 50
2022
Q3 		$614K Sell
5,875
-100
-2% -$11K 0.55% 52
2022
Q2 		$627K Sell
5,975
-67
-1% -$7.95K 0.52% 55
2022
Q1 		$772K Sell
6,042
-181
-3% -$21.8K 0.51% 57
2021
Q4 		$767K Sell
6,223
-181
-3% -$23.7K 0.48% 59
2021
Q3 		$909K Hold
6,404
– – 0.59% 58
2021
Q2 		$999K Sell
6,404
-118
-2% -$19.1K 0.63% 55
2021
Q1 		$1.01M Hold
6,522
– – 0.68% 50
2020
Q4 		$975K Sell
6,522
-3
-0% -$424 0.69% 53
2020
Q3 		$862K Hold
6,525
– – 0.69% 51
2020
Q2 		$756K Hold
6,525
– – 0.67% 51
2020
Q1 		$640K Buy
6,525
+51
+0.8% +$6.68K 0.69% 49
2019
Q4 		$940K Hold
6,474
– – 0.77% 44
2019
Q3 		$862K Sell
6,474
-721
-10% -$93.1K 0.74% 47
2019
Q2 		$822K Hold
7,195
– – 0.71% 48
2019
Q1 		$891K Hold
7,195
– – 0.79% 46
2018
Q4 		$724K Hold
7,195
– – 0.71% 46
2018
Q3 		$918K Sell
7,195
-206
-3% -$24.5K 0.78% 43
2018
Q2 		$800K Sell
7,401
-283
-4% -$30.8K 0.66% 51
2018
Q1 		$813K Sell
7,684
-1,123
-13% -$130K 0.7% 46
2017
Q4 		$1.03M Buy
8,807
+52
+0.6% +$5.88K 0.85% 40
2017
Q3 		$995K Buy
8,755
+340
+4% +$39.2K 0.85% 42
2017
Q2 		$1.05M Hold
8,415
– – 0.85% 41
2017
Q1 		$997K Hold
8,415
– – 0.83% 42
2016
Q4 		$843K Buy
+8,415
New +$902K 0.72% 50

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

A.D. Beadell Investment Counsel's ZBH Position: Q2 2024 in Review

A.D. Beadell Investment Counsel sold out of Zimmer Biomet (ZBH) in Q2 2024, closing a stake of 3,625 shares — an estimated $478K sold.

A.D. Beadell Investment Counsel first reported a position in ZBH in Q4 2016 and held it in 30 quarters. The position peaked at $1.05M in Q2 2017. 1,005 funds tracked by Wall St. Rank hold ZBH as of Q2 2024.

  • A.D. Beadell Investment Counsel reported no remaining Zimmer Biomet position as of Q2 2024 after selling out during the quarter.
  • A.D. Beadell Investment Counsel sold 3,625 Zimmer Biomet shares in Q2 2024, an estimated $478K.
  • A.D. Beadell Investment Counsel first reported a position in Zimmer Biomet in Q4 2016 and held it in 30 quarters.
  • A.D. Beadell Investment Counsel's Zimmer Biomet position peaked at $1.05M in Q2 2017.
  • 1,005 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2024.

Based on A.D. Beadell Investment Counsel's 13F filing for Q2 2024, filed 12 Jul 2024.